These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 32765477)

  • 21. Identification and Characterization of the HERV-K (HML-8) Group of Human Endogenous Retroviruses in the Genome.
    Liu M; Jia L; Guo X; Zhai X; Li H; Liu Y; Han J; Zhang B; Wang X; Li T; Wang Y; Li J; Yu C; Li L
    AIDS Res Hum Retroviruses; 2023 Apr; 39(4):176-194. PubMed ID: 36656667
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The intron-enriched HERV-K(HML-10) family suppresses apoptosis, an indicator of malignant transformation.
    Broecker F; Horton R; Heinrich J; Franz A; Schweiger MR; Lehrach H; Moelling K
    Mob DNA; 2016; 7():25. PubMed ID: 27980690
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of human endogenous retrovirus type K- related treatments for human diseases.
    Dai L; Fan J; Qin Z
    J Med Virol; 2024 Mar; 96(3):e29532. PubMed ID: 38497450
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HERV-K(HML-2) rec and np9 transcripts not restricted to disease but present in many normal human tissues.
    Schmitt K; Heyne K; Roemer K; Meese E; Mayer J
    Mob DNA; 2015; 6():4. PubMed ID: 25750667
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human Endogenous Retrovirus-K (HML-2)-Related Genetic Variation: Human Genome Diversity and Disease.
    Shin W; Mun S; Han K
    Genes (Basel); 2023 Nov; 14(12):. PubMed ID: 38136972
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The human endogenous retrovirus family HERV-K(HML-3).
    Mayer J; Meese EU
    Genomics; 2002 Sep; 80(3):331-43. PubMed ID: 12213204
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of human endogenous retroviral elements in the blood of HIV-1-infected individuals.
    Contreras-Galindo R; Kaplan MH; Contreras-Galindo AC; Gonzalez-Hernandez MJ; Ferlenghi I; Giusti F; Lorenzo E; Gitlin SD; Dosik MH; Yamamura Y; Markovitz DM
    J Virol; 2012 Jan; 86(1):262-76. PubMed ID: 22031938
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comprehensive identification and characterization of the HERV-K (HML-9) group in the human genome.
    Jia L; Liu M; Yang C; Li H; Liu Y; Han J; Zhai X; Wang X; Li T; Li J; Zhang B; Yu C; Li L
    Retrovirology; 2022 Jun; 19(1):11. PubMed ID: 35676699
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A role for human endogenous retrovirus-K (HML-2) in rheumatoid arthritis: investigating mechanisms of pathogenesis.
    Freimanis G; Hooley P; Ejtehadi HD; Ali HA; Veitch A; Rylance PB; Alawi A; Axford J; Nevill A; Murray PG; Nelson PN
    Clin Exp Immunol; 2010 Jun; 160(3):340-7. PubMed ID: 20345981
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comprehensive Characterization of the Human Endogenous Retrovirus HERV-K(HML-6) Group: Overview of Structure, Phylogeny, and Contribution to the Human Genome.
    Pisano MP; Grandi N; Cadeddu M; Blomberg J; Tramontano E
    J Virol; 2019 Aug; 93(16):. PubMed ID: 31167914
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human endogenous retrovirus family HERV-K(HML-5): status, evolution, and reconstruction of an ancient betaretrovirus in the human genome.
    Lavie L; Medstrand P; Schempp W; Meese E; Mayer J
    J Virol; 2004 Aug; 78(16):8788-98. PubMed ID: 15280487
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activation of HERV-K(HML-2) disrupts cortical patterning and neuronal differentiation by increasing NTRK3.
    Padmanabhan Nair V; Liu H; Ciceri G; Jungverdorben J; Frishman G; Tchieu J; Cederquist GY; Rothenaigner I; Schorpp K; Klepper L; Walsh RM; Kim TW; Cornacchia D; Ruepp A; Mayer J; Hadian K; Frishman D; Studer L; Vincendeau M
    Cell Stem Cell; 2021 Sep; 28(9):1566-1581.e8. PubMed ID: 33951478
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of human endogenous retrovirus type K (HML-2) is activated by the Tat protein of HIV-1.
    Gonzalez-Hernandez MJ; Swanson MD; Contreras-Galindo R; Cookinham S; King SR; Noel RJ; Kaplan MH; Markovitz DM
    J Virol; 2012 Aug; 86(15):7790-805. PubMed ID: 22593154
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection of HERV-K(HML-2) viral RNA in plasma of HIV type 1-infected individuals.
    Contreras-Galindo R; Kaplan MH; Markovitz DM; Lorenzo E; Yamamura Y
    AIDS Res Hum Retroviruses; 2006 Oct; 22(10):979-84. PubMed ID: 17067267
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gorillas have been infected with the HERV-K (HML-2) endogenous retrovirus much more recently than humans and chimpanzees.
    Holloway JR; Williams ZH; Freeman MM; Bulow U; Coffin JM
    Proc Natl Acad Sci U S A; 2019 Jan; 116(4):1337-1346. PubMed ID: 30610173
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression pattern analysis of transcribed HERV sequences is complicated by ex vivo recombination.
    Flockerzi A; Maydt J; Frank O; Ruggieri A; Maldener E; Seifarth W; Medstrand P; Lengauer T; Meyerhans A; Leib-Mösch C; Meese E; Mayer J
    Retrovirology; 2007 Jun; 4():39. PubMed ID: 17550625
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Upregulation of human endogenous retrovirus-K (HML-2) mRNAs in hepatoblastoma: Identification of potential new immunotherapeutic targets and biomarkers.
    Grabski DF; Ratan A; Gray LR; Bekiranov S; Rekosh D; Hammarskjold ML; Rasmussen SK
    J Pediatr Surg; 2021 Feb; 56(2):286-292. PubMed ID: 32682541
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The human endogenous retrovirus K(HML-2) has a broad envelope-mediated cellular tropism and is prone to inhibition at a post-entry, pre-integration step.
    Kramer P; Lausch V; Volkwein A; Hanke K; Hohn O; Bannert N
    Virology; 2016 Jan; 487():121-8. PubMed ID: 26517399
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of the protease cleavage sites in a reconstituted Gag polyprotein of an HERV-K(HML-2) element.
    George M; Schwecke T; Beimforde N; Hohn O; Chudak C; Zimmermann A; Kurth R; Naumann D; Bannert N
    Retrovirology; 2011 May; 8():30. PubMed ID: 21554716
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ancient Adversary - HERV-K (HML-2) in Cancer.
    Dervan E; Bhattacharyya DD; McAuliffe JD; Khan FH; Glynn SA
    Front Oncol; 2021; 11():658489. PubMed ID: 34055625
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.